Bisoprolol Sandoz 1.25 mg नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

bisoprolol sandoz 1.25 mg

sandoz a/s - bisoprololfumarat - tablett, filmdrasjert - 1.25 mg

Bisoprolol Sandoz 2.5 mg नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

bisoprolol sandoz 2.5 mg

sandoz a/s - bisoprololfumarat - tablett, filmdrasjert - 2.5 mg

Bisoprolol Sandoz 5 mg नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

bisoprolol sandoz 5 mg

sandoz a/s - bisoprololfumarat - tablett, filmdrasjert - 5 mg

Bisoprolol Sandoz 7.5 mg नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

bisoprolol sandoz 7.5 mg

sandoz a/s - bisoprololfumarat - tablett, filmdrasjert - 7.5 mg

Bisoprolol Sandoz 10 mg नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

bisoprolol sandoz 10 mg

sandoz a/s - bisoprololfumarat - tablett, filmdrasjert - 10 mg

Citalopram Sandoz 10 mg नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

citalopram sandoz 10 mg

sandoz (2) - citalopramhydrobromid - tablett, filmdrasjert - 10 mg

Citalopram Sandoz 20 mg नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

citalopram sandoz 20 mg

sandoz (2) - citalopramhydrobromid - tablett, filmdrasjert - 20 mg

Citalopram Sandoz 40 mg नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

citalopram sandoz 40 mg

sandoz (2) - citalopramhydrobromid - tablett, filmdrasjert - 40 mg

Regkirona यूरोपीय संघ - नॉर्वेजियाई - EMA (European Medicines Agency)

regkirona

celltrion healthcare hungary kft. - regdanvimab - covid-19 virus infection - immune sera og immunglobuliner, - regdanvimab is indicated for the treatment of adults with coronavirus disease 2019 (covid-19) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.

Lextemy यूरोपीय संघ - नॉर्वेजियाई - EMA (European Medicines Agency)

lextemy

mylan ire healthcare limited - bevacizumab - colorectal neoplasms; breast neoplasms; ovarian neoplasms; fallopian tube neoplasms; peritoneal neoplasms; carcinoma, non-small-cell lung; carcinoma, renal cell; uterine cervical neoplasms - antineoplastiske midler - treatment of carcinoma of the colon or rectum, breast cancer, non-small cell lung cancer, renal cell cancer, epithelial ovarian, fallopian tube or primary peritoneal cancer, and carcinoma of the cervix.